Development and Validation of a Computational Method for Assessment of Missense Variants in Hypertrophic Cardiomyopathy
- 11 February 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 88 (2), 183-192
- https://doi.org/10.1016/j.ajhg.2011.01.011
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 GM078598, T32 GM008313)
This publication has 29 references indexed in Scilit:
- Human allelic variation: perspective from protein function, structure, and evolutionCurrent Opinion in Structural Biology, 2010
- Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic CardiomyopathyAnnals of Internal Medicine, 2010
- Do common in silico tools predict the clinical consequences of amino‐acid substitutions in the CFTR gene?Clinical Genetics, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Evidence From Human Myectomy Samples That MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy Through HaploinsufficiencyCirculation Research, 2009
- Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methodsHuman Mutation, 2009
- In silico analysis of missense substitutions using sequence-alignment based methodsHuman Mutation, 2008
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Crystallographic findings on the internally uncoupled and near-rigor states of myosin: Further insights into the mechanics of the motorProceedings of the National Academy of Sciences of the United States of America, 2002
- Predicting Deleterious Amino Acid SubstitutionsGenome Research, 2001